71 related articles for article (PubMed ID: 1635923)
1. Effect of AWD 52-39 on vasoconstriction induced by noradrenaline and 5-hydroxytryptamine in vitro and in vivo in rats.
Müller H; Glusa E
Pharmazie; 1992 Feb; 47(2):137-9. PubMed ID: 1635923
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
3. Receptors for 5-hydroxytryptamine in rabbit blood vessels: activation of alpha adrenoceptors in rabbit thoracic aorta.
Purdy RE; Murray DL; Stupecky GL
J Pharmacol Exp Ther; 1987 Feb; 240(2):535-41. PubMed ID: 2879909
[TBL] [Abstract][Full Text] [Related]
4. Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.
Quinn ST; Guiry PJ; Schwab T; Keenan AK; McBean GJ
Auton Autacoid Pharmacol; 2006 Oct; 26(4):335-44. PubMed ID: 16968472
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats.
Orallo F
Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
Russell A; Banes A; Berlin H; Fink GD; Watts SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?
van Meijeren CE; Vleeming W; van de Kuil T; Gerards AL; Hendriksen CF; de Wildt DJ
Eur J Pharmacol; 2004 Jun; 493(1-3):139-50. PubMed ID: 15189775
[TBL] [Abstract][Full Text] [Related]
9. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.
Xu Z; Purdy RE
J Pharmacol Exp Ther; 1989 Mar; 248(3):1091-5. PubMed ID: 2564889
[TBL] [Abstract][Full Text] [Related]
10. Influence of endothelium on the vasoconstrictor effect of dihydroergotamine in pithed rats.
Müller H; Glusa E
Arch Int Pharmacodyn Ther; 1991; 313():120-8. PubMed ID: 1816759
[TBL] [Abstract][Full Text] [Related]
11. Influence of 5-hydroxytryptamine on the pressor responses induced by norepinephrine and electrical sympathetic stimulation in the pithed rat.
Terrón JA; Sánchez-López A; Ramírez-San Juan E; Castillo C; Villalón CM
Arch Med Res; 1996; 27(3):291-7. PubMed ID: 8854384
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
14. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
15. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
18. Mutual-effect amplification of contractile responses elicited by simultaneous activation of alpha-1 adrenergic and 5-hydroxytryptamine2 receptors in isolated rat aorta.
Christ GJ; Jean-Jacques M
J Pharmacol Exp Ther; 1991 Feb; 256(2):553-61. PubMed ID: 1847200
[TBL] [Abstract][Full Text] [Related]
19. Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation.
Kawasaki H; Takasaki K
J Pharmacol Exp Ther; 1984 Jun; 229(3):816-22. PubMed ID: 6427449
[TBL] [Abstract][Full Text] [Related]
20. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
